UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
AMERICAN HEALTHCHOICE, INC.
(Name of Issuer)
Common Stock, Par Value $0.001
(Title of Class of Securities)
025929 10 0
(CUSIP Number)
Dr. J.W. Stucki, 1300 W. Walnut Hill Lane, Suite 275, Irving, Texas 75038
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
Various
(Date of Event which Requires Filing of this Settlement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D,
and is filing this schedule because of Rule 13d-1(b)(3) or (4), check
the following box.
Check the following box if a fee is being paid with the statement.
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five
percent of the class of securities described in Item 1; and (2) has
filed no amendment subsequent thereto reporting beneficial ownership of
five percent or less of such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom
copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
SCHEDULE 13D
CUSIP NO. 025929 10 0 Page 2 of 6 Pages
-----------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. J.W. Stucki
-----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [X]
-----------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
-----------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR (e) [ ]
-----------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
-----------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 9,556,328
SHARES -------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH -0-
REPORTING -------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
9,556,328
-------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
-----------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,556,328
-----------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
-----------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
33.0%
-----------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
-----------------------------------------------------------------------
<PAGE>
Item 1. Security and Issuer.
This statement relates to shares of Common Stock, par value $0.001
per share, of American HealthChoice, Inc., a New York corporation (the
"Issuer"), with principal executive offices at 1300 W. Walnut Hill
Lane, Suite 275, Irving, Texas 75038.
Item 2. Identity and Background.
This statement is filed with respect to the ownership of 9,556,328
shares of the Issuer's Common Stock, consisting of 9,356,328 shares
owned of record and 200,000 shares issuable upon exercise of stock
options. The following information is provided regarding the owner:
(a) Name: Dr. J.W. Stucki
(b) Business Address: 1300 W. Walnut Hill Lane, Suite 275
Irving, Texas 75038
(c) Principal Occupation: Chief Executive Officer,
American HealthChoice, Inc.
(d) Registrant has not, during the past five years, been
convicted in any criminal proceeding (excluding traffic
violations and similar misdemeanors).
(e) Registrant has not, during the past five years, been a party
to a civil proceeding of a judicial or administrative body of
competent jurisdiction or been subject to a judgment, decree
or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such
laws.
Item 3. Source and Amount of Funds, or Other Consideration.
Personal funds.
Item 4. Purpose of Transaction.
The Issuer was formed in 1988 as Paduan, Inc. for the purpose of
acquiring an operating business with a potential for future growth.
The Issuer had no operations until March 1995, when it acquired
American HealthChoice, Inc., a Delaware corporation ("AHDEL"), which
operated six clinics providing medical, chiropractic and physical
therapy services in Texas and Louisiana. The Issuer issued 4,962,000
shares of its Common Stock to the shareholders of AHDEL representing
91.6% of the Issuer's voting shares. The Registrant was a shareholder
of AHDEL and acquired 2,644,322 shares, representing 49% of shares
outstanding in exchange for his AHDEL shares.
<PAGE>
On March 5, 1998, Registrant reported ownership of 2,544,059
shares of common stock of the Issuer. The following transactions in
such stock have occurred since that date:
On June 1, 1998, Registrant acquired 50,000 shares from the Issuer
pursuant to his employment agreement.
On August 8, 1998, Registrant returned 111,739 shares in exchange
for reinstatement of promissory note in the principal amount of
$439,973.
On December 17, 1998, Registrant acquired 6,000,523 shares upon
conversion of a promissory note in the principal amount of $132,012.
On June 1, 1999, Registrant acquired 50,000 shares from the Issuer
pursuant to his employment agreement.
On June 10, 1999, Registrant acquired 348,485 shares of common
stock at par value as additional consideration for making a $30,000
loan to the Company.
On June 25, 1999, Registrant acquired 250,000 shares of common
stock at par value as additional consideration for making a $20,000
loan to the Company.
On August 8, 1999, Registrant acquired 400,000 shares of common
stock at par value as additional consideration for making a $25,000
loan to the Company.
The three foregoing transactions were approved by a disinterested
majority of the Board of Directors. The number of shares was
determined in each case by dividing the amount of the loans by the
trading value of the common stock on the date of the loans.
On December 31, 1999, Registrant sold 100,000 shares of common
stock to his brother for a price of $0.015 per share.
On January 19, 2000, Registrant sold 25,000 shares of common stock
under Rule 144 for a price of $0.12 per share.
On January 24, 2000, Registrant sold 30,000 shares of common stock
under Rule 144 for a price of $0.35 per share.
On January 25, 2000, Registrant sold 20,000 shares of common stock
under Rule 144 for a price of $0.52 per share.
The purpose of the transactions in such shares has been to
maintain a proprietary stake in and assist in the financing of a
growing public company that can acquire health care clinics and
facilities to compete in the managed care market. Transactions during
2000 were made to obtain some needed liquidity. Registrant takes an
active role in the management of the Issuer and is Chairman and Chief
Executive Officer.
<PAGE>
Registrant has no present plan or proposal which would relate to
or result in: (a) the acquisition of additional securities of the
Issuer (except for issuance of 50,000 shares per year due under the
terms of his Employment Agreement); (b) any extraordinary corporate
transaction involving the Issuer; (c) a sale or transfer of a material
amount of assets of the Issuer or its subsidiaries; (d) any change in
the Board of Directors of the Issuer; (e) any material change in the
Issuer's capitalization or dividend policy; (f) any other material
change in the Issuer's business or corporate structure; (g) any change
in the Issuer's Articles of Incorporation or Bylaws which may impede
the acquisition of control of the Issuer; (h) cause any securities of
the Issuer to be delisted from the OTCBB; or (i) any class of equity
securities of the Issuer becoming eligible for termination of
registration pursuant to Section 12(g)(4) of the Securities act of
1933.
Item 5. Interests in Securities of the Issuer.
(a) 9,556,328 shares (33% of shares outstanding) consisting of
9,356,328 shares and options to acquire 200,000 shares.
(b) Dr. J.W. Stucki - sole power to vote and dispose.
(c) See Item 4.
(d) None.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer.
(a) Registrant is entitled to receive options to acquire 50,000
shares per year for service as the Issuer's Chief Executive Officer.
(b) Also see the arrangements described in Item 4.
Item 7. Material to be Filed as Exhibits.
None
Signature
After reasonable inquiry and to the best of my information and
belief, I certify that the information set forth in this statement is
true, complete, and correct.
February 9, 2000 /s/ J.W. Stucki
---------------- ---------------
Date Dr. J.W. Stucki
